Aldosterone Antagonists [Eplerenone] in Systemic Right Ventricle: a Randomized Clinical Trial.

Trial Profile

Aldosterone Antagonists [Eplerenone] in Systemic Right Ventricle: a Randomized Clinical Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Right ventricular dysfunction
  • Focus Biomarker; Therapeutic Use
  • Acronyms EVEDES
  • Most Recent Events

    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
    • 30 Nov 2011 Actual patient number is 26 according to ClinicalTrials.gov.
    • 30 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top